Increased tirzepatide use for glycemic and weight control since United States market entry
1. In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval in the United States ...
Tag: sodium-glucose cotransporter 2 (SGLT2) inhibitors
#VisualAbstract: Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Do Not Improve Survival Free of Organ Support in COVID-19
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Empagliflozin does not decrease risk of hospitalization or death after myocardial infarction
1. In this randomized controlled trial, empagliflozin was not shown to decrease the risk of hospitalization for heart failure or ...